CholestMD

product on market Capsule 1MD Safety: 94/100
94/100

This product looks safe

  • Niacinamide: 380mg is 10.9× the Tolerable Upper Intake Level (35mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile features red yeast rice and Bergavit, which have moderate to strong evidence for supporting healthy cholesterol levels. Niacin and pine bark extract are included to further target lipid profiles, though evidence for some components is more limited. The formulation maintains a high safety score of 94/100.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacinamide: 380mg is 10.9× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for CholestMD
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Bergavit
550 mg
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
380 mg (2375% DV)
Exceeds UL by 10.9× (UL: 35 mg) 196 studies (A:5, B:63)
1000 mg
Market median: 1000.0mg (223 products) 11 studies (A:0, B:5)
Pine bark extract
20 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)

Other Ingredients

Vegetable Cellulose Capsule Silica Vegetable Oil powder
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, adults take three (3) capsules daily, with an 8-ounce glass of water, or as recommended by a healthcare professional.

Warnings & Precautions

Warning: Consult your physician before using this or any product if you are pregnant, nursing, trying to conceive, taking medications such as blood thinners, anticoagulants, immunosuppressants, photosensitizing medications, or other medications, have a sensitivity to sunlight, have coagulopathy, a liver or kidney condition, or any other known medical condition.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Promotes cholesterol health Promotes HDL production Aids in triglyceride reduction Supports heart health

Gluten-free Non-GMO Sugar-free Soy-free Preservative-free

Vegan

Additional Information

Store in a cool, dry place.

Made in USA GMP Good Manufacturing Practice

Doctor recommended

Metadata

Product Details

UPC / SKU8 50008 02115 2
DSLD Entry Date2021-03-25
Product TypeOther Combinations
FormCapsule
Brand1MD
DSLD ID246725
Data Updated2026-04-11
Research

Research Evidence

13
Research Sources
53
Avg Quality
5
Rct
5
Meta Analysis
2
Clinical Trial
1
Regulatory Source
B Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials
Meta Analysis Expert review of clinical pharmacology 2023 PubMed DOI
B Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial
Rct Nutrients 2023 PubMed DOI
B Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults
Meta Analysis The American journal of nursing 2017 PubMed DOI
B Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia
Rct Nutrients 2022 PubMed DOI
B Low dose red yeast rice with monacolin K lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: A multicenter, randomized trial
Rct Asia Pacific journal of clinical nutrition 2021 PubMed DOI
C Impact of Monacolin K-Containing Supplements on Lipid Profile: A Meta-Analysis of Randomised Controlled Trials
Meta Analysis Endocrinology, diabetes & metabolism 2026 PubMed DOI
C Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis
Meta Analysis Atherosclerosis 2015 PubMed DOI
C Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials
Meta Analysis Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2016 PubMed DOI
C Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial
Rct BMC complementary and alternative medicine 2015 PubMed DOI
C No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial
Rct Chinese journal of integrative medicine 2017 PubMed DOI
View all evidence for Red Yeast Rice →
Compare

Similar Products

View all Red Yeast Rice products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.